Table 3.

Clearance of HPV infection by HPV type among HIV-1–seropositive (CD4+ > 500 and CD4+ ≤ 500) and HIV-1–seronegative individuals with IL10 GCC haplotype

HPV typeHIV-1 seropositive
HIV-1 seronegative
CD4+ ≤ 500
CD4+ > 500
n/event*RH (95% CI)Pn/event*RH (95% CI)Pn/event*RH (95% CI)P
HPV16-like66/460.48 (0.26-0.88)0.0166/370.81 (0.422-1.54)0.5146/321.68 (0.82-3.44)0.15
HPV18-like58/330.34 (0.17-0.69)0.00265/400.67 (0.36-1.24)0.2046/331.21 (0.61-2.40)0.58
High risk81/470.38 (0.21-0.68)0.00284/430.74 (0.40-1.34)0.3261/391.78 (0.94-3.38)0.08
Low risk50/300.60 (0.29-1.25)0.1756/361.80 (0.91-3.56)0.0925/210.98 (0.41-2.30)0.95
  • * n = total number of individuals; event = total individuals who cleared.